LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway

Neurotherapeutics - United States
doi 10.1007/s13311-018-0649-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis

OncoTargets and Therapy
OncologyPharmacology
2020English

LncRNA LOXL1‐AS1 Facilitates the Tumorigenesis and Stemness of Gastric Carcinoma via Regulation of miR‐708‐5p/USF1 Pathway

Cell Proliferation
MedicineCell Biology
2019English

LncRNA HULC Enhances Epithelial-Mesenchymal Transition to Promote Tumorigenesis and Metastasis of Hepatocellular Carcinoma via the miR-200a-3p/ZEB1 Signaling Pathway

Oncotarget
Oncology
2016English

Long Noncoding RNA SNHG17 Induced by YY1 Facilitates the Glioma Progression Through Targeting miR-506-3p/CTNNB1 Axis to Activate WNT/Β-Catenin Signaling Pathway

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Knockdown of lncRNA PVT1 Alleviates High Glucose-Induced Proliferation and Fibrosis in Human Mesangial Cells by miR-23b-3p/WT1 Axis

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

LncRNA NEAT1 Enhances the Radio-Resistance of Cervical Cancer via miR-193b-3p/CCND1 Axis

Oncotarget
Oncology
2017English

Linc00152 Promotes Malignant Progression of Glioma Stem Cells by Regulating miR-103a-3p/FEZF1/CDC25A Pathway

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

Upregulated lncRNA SNHG1 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-101-3p and Activation of WNT/Β-Catenin Signaling Pathway

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy